Reuters: Investors Return to US stocks as AI earnings Growth Feed Fear of Missing Out

By: Laura Matthews, featuring: Ed O’ Gorman, MBA, CFA®


U.S. stocks are rebounding and investors, reassured by diplomacy around the Iran war, are coming off the sidelines as AI-related spending and ​a strong start to the earnings season fuel a new fear: missing out on stocks' latest rally.

"The market will do whatever it has to do to prove the ‌most people wrong. It's rallied 10% here in a very short period of time. Most people missed it," said Todd Morgan, chairman of Bel Air Investment Advisors. "We've slowly added new money back into the market the last week or two, believing that there's a light at the end of the tunnel."

The S&P 500 (.SPX), opens new tab has risen 11% from its March low and in recent days hit successive record closing highs, after falling 8% in the weeks following the February 28 U.S.-Israeli attack ​on Iran.

The disruption of shipping through the Strait of Hormuz, a major oil export route, raised the risk of an energy-driven surge in inflation. Risk appetite took a significant hit ​on fears that the war would become prolonged and escalate into a regional conflict, further disrupting energy supplies and triggering a global economic shock.

But a ceasefire ⁠between the U.S. and Iran has since helped to soothe nerves, while resilient first-quarter profits and economic data showing the U.S. economy remains on strong footing gave investors additional encouragement to wade back ​in.

Fear of missing out, or FOMO, appears now to be a powerful force.

Data from Deutsche Bank showed investors' equity positioning for the week ended April 17 logged one of its largest weekly jumps since 2010, although it remains only slightly above neutral.

"Every day is a good day to put long-term capital to work," said Seth Hickle, a portfolio manager at Mindset Wealth Management. "Even with elevated valuation ratios, the growth ​outlook remains strong for U.S. stocks."

Investors who spoke to Reuters are investing in technology, industrials and financials, with strong interest in AI, data centers, small caps and select emerging markets. The tech-heavy Nasdaq (.IXIC), opens new tab has ​advanced about 18% from its late March low, while an index of emerging market stocks (.MSCIEF), opens new tab has risen 15%.

Energy stocks remain an attractive bet, investors said, with oil expected to retain a supply-driven premium for several quarters even ‌if prices soften. ⁠Brent crude futures are trading about 40% above their late February level.

Investors are also turning to materials and commodities to round out their portfolios, drawn by two long-term demand drivers: AI-linked capital expenditures and rising geopolitical uncertainty, both of which are expected to lift defense and infrastructure spending — and with it, materials prices.

"It's a bet that the earnings growth story holds and that earnings growth is going to support valuations," said Edward O'Gorman, MBA, CFA CEO of River Wealth Advisors. "If we get back to a Fed cutting interest rates, that's a little bit of a tailwind."

Expectations for 2026 year-over-year earnings growth have leapt from 16% in early ​January to almost 20% last week, according to ​data from LSEG I/B/E/S. Technology companies account for ⁠the bulk of that increase, along with energy and materials companies.

Click here to read the full article.

Source: Matthews, Laura. “Investors Return to Us Stocks as AI, Earnings Growth Feed Fear of Missing out | Reuters.” Investors return to US stocks as AI, earnings growth feed fear of missing out, April 23, 2026. https://www.reuters.com/business/investors-return-us-stocks-ai-earnings-growth-feed-fear-missing-out-2026-04-23/.

Disclosure: The scope of any financial planning and consulting services to be provided depends upon the terms of the engagement, and the specific request and needs of the client. River Wealth Advisors LLC (“River Wealth”) does not serve as an attorney, accountant, or insurance agent. River Wealth does not prepare estate planning documents or tax returns, nor does it sell insurance products. Click here to review our social media disclosures.

Taylor Schultz